You searched for "Supporting"

2038 results found

Posterior capsular rupture risk factors as reported in the European registry

In this cross-sectional review of the European Registry of Quality Outcomes for Cataract and Refractive Surgery (EUREQUO) including 2,853,376 patients and 31,749 cases with posterior capsular rupture (PCR), the authors observed a trend of reduction in PCR rate from 1.44%...

Natural history of idiopathic intracranial hypertension depending on incidental or symptomatic presentation

The authors present a large retrospective review cohort of consecutive patients diagnosed or presumed idiopathic intracranial hypertension (IIH) over a three-year period at a single tertiary centre. Patients on medication with a known aetiology for IIH were excluded. The cohort...

Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases

This is a retrospective study of patients with ocular surface inflammatory diseases (OSIDs) treated with IKERVIS in a single centre between 2016 to 2019 with at least six months follow-up. Clinical outcome was defined as successful (resolved or stable disease),...

Narrative review of opsoclonus myoclonus ataxia syndrome following COVID-19

Opsoclonus myoclonus syndrome (OMS) / opsoclonus myoclonus ataxia syndrome (OMAS) is a rare central nervous system manifestation of COVID-19, but an increasing number of articles have reported patients in whom COVID-19 was complicated by OMS / OMAS. This narrative review...

Portable vision reading device shows promise for low vision after brain injury

The authors report a small sample cohort study evaluating the impact of a portable vision reading device (OrCam Read) on vision-related quality-of-life and independent functional status in patients with low vision due to stroke or brain tumours. Six patients with...

Updated staging of LCHADD retinopathy

The authors present their proposal for an updated staging system for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) deficiency retinopathy. This is a rare mitochondrial disease due to deficiency of the long chain fatty acid oxidation pathway. Forty patients who were part of...

What characteristics are linked with adolescent blindness and severe visual impairment

The authors present a retrospective cohort analysis which aimed to characterise the risk factors for adolescents being blind or severely visually impaired. The publicly available National Survey of Drug Use and Health (NSDUH) was used as the data source and...

Smartphone use in adolescents and association with ocular symptoms and binocular issues

In this study, the proportion of ocular symptoms and binocular dysfunction was evaluated to determine their association with smartphone use on adolescents aged 10–19 years. This was a cross-sectional study of 123 participants (52% male, 48% female) with a mean...

Strabismus prevalence in a Pakistan population

The aim of this study was to compile the available literature reporting the prevalence of strabismus in Pakistan and calculate the pooled prevalence of strabismus in the Pakistan population. Meta analysis was conducted with 10 studies with a total of...

Glaukos marks major milestone as global iStent sales reach 3 million

Glaukos is delighted to announce a major milestone revealing that 3 million iStents have been sold globally since the product first received approval from the FDA in 2012. Today iStent is the global market leader in the MIGs category with...

Idebenone for Leber hereditary optic neuropathy

The authors present a meta-analysis of studies reporting the effects of idebenone treatment on visual acuity (VA) in patients with Leber hereditary optic neuropathy (LHON), the most common inherited mitochondrial disorder. They included randomised controlled trials, non-randomised controlled trials and...

Retinoblastoma management update (part 1): clinical features, diagnosis and genetics

The first of a two part series, this article will discuss the clinical features, diagnosis and genetic aspects of retinoblastoma. Manoj Parulekar is based at Birmingham Children’s Hospital, one of the two designated national retinoblastoma and paediatric ocular oncology treatment...